209 related articles for article (PubMed ID: 35042263)
1. Classical and Molecular Techniques to Diagnose HAP/VAP.
Renaud C; Kollef MH
Semin Respir Crit Care Med; 2022 Apr; 43(2):219-228. PubMed ID: 35042263
[TBL] [Abstract][Full Text] [Related]
2. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.
Pugh R; Grant C; Cooke RP; Dempsey G
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007577. PubMed ID: 26301604
[TBL] [Abstract][Full Text] [Related]
3. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
Werarak P; Kiratisin P; Thamlikitkul V
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
[TBL] [Abstract][Full Text] [Related]
4. Emerging trends of nosocomial pneumonia in intensive care unit of a tertiary care public teaching hospital in Western India.
Bhadade R; Harde M; deSouza R; More A; Bharmal R
Ann Afr Med; 2017; 16(3):107-113. PubMed ID: 28671150
[TBL] [Abstract][Full Text] [Related]
5. The Distribution of Multidrug-resistant Microorganisms and Treatment Status of Hospital-acquired Pneumonia/Ventilator-associated Pneumonia in Adult Intensive Care Units: a Prospective Cohort Observational Study.
Chang Y; Jeon K; Lee SM; Cho YJ; Kim YS; Chong YP; Hong SB
J Korean Med Sci; 2021 Oct; 36(41):e251. PubMed ID: 34697926
[TBL] [Abstract][Full Text] [Related]
6. Application of a multiplex molecular pneumonia panel and real-world impact on antimicrobial stewardship among patients with hospital-acquired and ventilator-associated pneumonia in intensive care units.
Chen CL; Tseng HY; Chen WC; Liang SJ; Tu CY; Lin YC; Hsueh PR
J Microbiol Immunol Infect; 2024 Jun; 57(3):480-489. PubMed ID: 38471985
[TBL] [Abstract][Full Text] [Related]
7. Considerations unique to pediatrics for clinical trial design in hospital-acquired pneumonia and ventilator-associated pneumonia.
Bradley JS
Clin Infect Dis; 2010 Aug; 51 Suppl 1():S136-43. PubMed ID: 20597664
[TBL] [Abstract][Full Text] [Related]
8. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.
Pugh R; Grant C; Cooke RP; Dempsey G
Cochrane Database Syst Rev; 2011 Oct; (10):CD007577. PubMed ID: 21975771
[TBL] [Abstract][Full Text] [Related]
9. Aetiology of hospital-acquired pneumonia and trends in antimicrobial resistance.
Enne VI; Personne Y; Grgic L; Gant V; Zumla A
Curr Opin Pulm Med; 2014 May; 20(3):252-8. PubMed ID: 24614243
[TBL] [Abstract][Full Text] [Related]
10. Single-drug versus combination antimicrobial therapy in critically ill patients with hospital-acquired pneumonia and ventilator-associated pneumonia due to Gram-negative pathogens: a multicenter retrospective cohort study.
Barbier F; Dupuis C; Buetti N; Schwebel C; Azoulay É; Argaud L; Cohen Y; Hong Tuan Ha V; Gainnier M; Siami S; Forel JM; Adrie C; de Montmollin É; Reignier J; Ruckly S; Zahar JR; Timsit JF;
Crit Care; 2024 Jan; 28(1):10. PubMed ID: 38172969
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic resistance in nosocomial respiratory infections.
Denys GA; Relich RF
Clin Lab Med; 2014 Jun; 34(2):257-70. PubMed ID: 24856527
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic treatment of hospital-acquired pneumonia: is it different from ventilator-associated pneumonia?
Niederman MS
Curr Opin Crit Care; 2018 Oct; 24(5):353-360. PubMed ID: 30028739
[TBL] [Abstract][Full Text] [Related]
13. Understanding the Concept of Health Care-Associated Pneumonia in Lung Transplant Recipients.
Palacio F; Reyes LF; Levine DJ; Sanchez JF; Angel LF; Fernandez JF; Levine SM; Rello J; Abedi A; Restrepo MI
Chest; 2015 Aug; 148(2):516-522. PubMed ID: 25742187
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for antibiotic resistance in hospital-acquired and ventilator-associated pneumonia.
Sano M; Shindo Y; Takahashi K; Okumura J; Sakakibara T; Murakami Y; Iguchi M; Yagi T; Matsui S; Hasegawa Y
J Infect Chemother; 2022 Jun; 28(6):745-752. PubMed ID: 35219577
[TBL] [Abstract][Full Text] [Related]
15. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
Eachempati SR; Hydo LJ; Shou J; Barie PS
J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
[TBL] [Abstract][Full Text] [Related]
16. Review of health economic models exploring and evaluating treatment and management of hospital-acquired pneumonia and ventilator-associated pneumonia.
Wagner AP; Enne VI; Livermore DM; Craig JV; Turner DA;
J Hosp Infect; 2020 Dec; 106(4):745-756. PubMed ID: 32971194
[TBL] [Abstract][Full Text] [Related]
17. Impact of Molecular Syndromic Diagnosis of Severe Pneumonia in the Management of Critically Ill Patients.
Stafylaki D; Maraki S; Vaporidi K; Georgopoulos D; Kontoyiannis DP; Kofteridis DP; Chamilos G
Microbiol Spectr; 2022 Oct; 10(5):e0161622. PubMed ID: 36154180
[TBL] [Abstract][Full Text] [Related]
18. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of Ventilator-Associated Pneumonia, microbiological diagnostics and the length of antimicrobial treatment in the Polish Intensive Care Units in the years 2013-2015.
Wałaszek M; Różańska A; Wałaszek MZ; Wójkowska-Mach J;
BMC Infect Dis; 2018 Jul; 18(1):308. PubMed ID: 29976151
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of doripenem versus meropenem for hospital-acquired and ventilator-associated pneumonia.
Liu WD; Shih MC; Chuang YC; Wang JT; Sheng WH
J Microbiol Immunol Infect; 2019 Oct; 52(5):788-795. PubMed ID: 31155463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
